Bangalore, Apr 28: Biocon, the Bangalore based biotechnology firm on Tuesday, Apr 28 posted a net profit of Rs 24.88 crore for the quarter ended Mar 31, 2009, a 62 pc decline over the same period a year ago.
"(The) fiscal year '09 has been one of our most challenging years wherein foreign currency volatility made it difficult to manage a sharply depreciating rupee resulting in large MTM losses," said Kiran Mazumdar Shaw, the Biocon Chairman and Managing Director.
In the quarter ended on Mar 31, 2008 Biocon had a net profit of Rs 65.30 cr. The company's consolidated total income rose to Rs 486.56 crore for the fourth quarter ended Mar 31, 2009, from Rs 279.22 cr a year ago, Biocon said in a filing to the Bombay Stock Exchange.
OneIndia News
"(The) fiscal year '09 has been one of our most challenging years wherein foreign currency volatility made it difficult to manage a sharply depreciating rupee resulting in large MTM losses," said Kiran Mazumdar Shaw, the Biocon Chairman and Managing Director.
In the quarter ended on Mar 31, 2008 Biocon had a net profit of Rs 65.30 cr. The company's consolidated total income rose to Rs 486.56 crore for the fourth quarter ended Mar 31, 2009, from Rs 279.22 cr a year ago, Biocon said in a filing to the Bombay Stock Exchange.
OneIndia News
Oneindia Login